Our Centre in Severe Asthma will develop helpful toolkits and checklists to help with severe asthma diagnosis, management and treatments. As we continue to develop these outputs, they will be made available through this website page.
Clinical Recommendations For The Use Of Omalizumab In Severe Asthma:
This document was developed by the Centre of Excellence in Severe Asthma. It provides an overview of omalizumab treatment, eligibility criteria, enrolment, precautions/adverse effects and procedures for administration. This document has been developed as a guide only. Any local recommendations and requirements must be considered when implementing these recommendations into practice..